[HTML][HTML] Current strategies for the manufacture of small size tissue engineering vascular grafts
M Carrabba, P Madeddu - Frontiers in bioengineering and …, 2018 - frontiersin.org
Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts
M Carrabba, P Madeddu - Frontiers in bioengineering …, 2018 - pubmed.ncbi.nlm.nih.gov
Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
[引用][C] Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts
M Carrabba, P Madeddu - Frontiers in Bioengineering and …, 2018 - cir.nii.ac.jp
Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
[HTML][HTML] Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts
M Carrabba, P Madeddu - Frontiers in Bioengineering and …, 2018 - ncbi.nlm.nih.gov
Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts.
M Carrabba, P Madeddu - Frontiers in Bioengineering and …, 2018 - europepmc.org
Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
Current Strategies for the manufacture of Small Size Tissue Engineering Vascular Graft
M Carrabba, P Madeddu - Frontiers in …, 2018 - research-information.bris.ac.uk
Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
[PDF][PDF] Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts
M Carrabba, P Madeddu - core.ac.uk
Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
[PDF][PDF] Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts
M Carrabba, P Madeddu - Frontiers in Bioengineering and … - research-information.bris.ac.uk
Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
Current Strategies for the Manufacture of Small Size Tissue Engineering Vascular Grafts.
M Carrabba, P Madeddu - Frontiers in Bioengineering and …, 2018 - europepmc.org
Occlusive arterial disease, including coronary heart disease (CHD) and peripheral arterial
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …
disease (PAD), is the main cause of death, with an annual mortality incidence predicted to …